This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors t…

Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more

~Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT03866382

Phase 2

Phase II Study of Enfortumab Vedotin Treatment for Metastatic Squamous Cell Carcinoma of the Penis

This phase II trial tests how well enfortumab vedotin works for treating patients with squamous cell carcinoma of the penis that has spread to other places in …

Metastatic Penile Squamous Cell CarcinomaStage III Penile Cancer AJCC v8Stage IV Penile Cancer AJCC v8+1 more

~Estimated

~$10 – $6,250

Mayo ClinicNCT06104618